Related Experiment Video

Updated: Jul 15, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

Pediatric cancer: The King Faisal Specialist Hospital and Research Centre experience

A A Al-Nasser1, R M Al-Sudairy, H Solh

  • 1Department of Oncology, MBC-64, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Annals of Saudi Medicine
|September 1, 1996
PubMed

Insights

This study analyzed 3291 pediatric cancer cases treated in Saudi Arabia from 1976-1993. Leukemias, lymphomas, and central nervous system (CNS) tumors were the most common childhood malignancies.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Cancer Research

Background:

  • King Faisal Specialist Hospital and Research Centre (KFSH&RC) is a major treatment center for childhood cancers in Saudi Arabia.
  • Understanding the epidemiology of pediatric malignancies is crucial for public health planning and resource allocation.

Purpose of the Study:

  • To present epidemiologic data on childhood malignancies treated at KFSH&RC between 1976 and 1993.
  • To identify the most common types of cancer and demographic characteristics in this pediatric population.

Main Methods:

  • Retrospective analysis of a large cohort of pediatric cancer patients.
  • Data collection included patient demographics, cancer type, and treatment period.

Main Results:

  • A total of 3291 children with cancer were treated.
  • Leukemias (26.2%), lymphomas (21.3%), and central nervous system (CNS) tumors (15.3%) were the most frequent malignancies.
  • The peak age for cancer diagnosis was between two and five years, with a male to female ratio of 1.5:1.

Conclusions:

  • This study provides valuable insights into the patterns of childhood cancer in Saudi Arabia during the specified period.
  • The findings highlight the significant burden of leukemias, lymphomas, and CNS tumors in the pediatric population treated at a single institution.

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...